Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Choosing Wisely in Surgical Oncology
Prof Shailesh Shrikhande - Tata Memorial Centre, Mumbai, India
Choosing Wisely in Surgical Oncology ( Prof Shailesh Shrikhande - Tata Memorial Centre, Mumbai, India )
6 Oct 2021
Choosing Wisely in Precision oncology
Dr Sanjay Popat -The Royal Marsden Hospital, London, UK
Choosing Wisely in Precision oncology ( Dr Sanjay Popat  -The Royal Marsden Hospital, London, UK )
6 Oct 2021
Choosing to using wisely in Screening/Early diagnosis
Dr Ophira Gingsburg - International Agency for Research on Cancer (IARC)/ WHO, U...
Choosing to using wisely in Screening/Early diagnosis ( Dr Ophira Gingsburg - International Agency for Research on Cancer (IARC)/ WHO, USA )
6 Oct 2021
Choosing wisely Africa
Dr Nazik Hammad - Queen's University, Kingston, Canada.
Choosing wisely Africa ( Dr Nazik Hammad - Queen's University, Kingston, Canada. )
6 Oct 2021
Choosing Trials Wisely: What type of clinical trials should be a priority for LM...
Dr Bishal Gyawali - Queen's University, Kingston, Canada and Department of Medi...
Choosing Trials Wisely: What type of clinical trials should be a priority for LMICs? ( Dr Bishal Gyawali  - Queen's University, Kingston, Canada and Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA )
6 Oct 2021
First-line nivolumab + ipilimumab + chemo in patients with advanced NSCLC and br...
Dr David Paul Carbone - The Ohio State University Medical Center, Ohio, USA
First-line nivolumab + ipilimumab + chemo in patients with advanced NSCLC and brain metastases: Results From CheckMate 9LA ( Dr David Paul Carbone - The Ohio State University Medical Center, Ohio, USA )
6 Oct 2021
Trastuzumab deruxtecan vs trastuzumab emtansine in patients with HER2+ metastati...
Dr Javier Cortés - Hospital Universitario Ramón y Cajal, Madrid, Spain
Trastuzumab deruxtecan vs trastuzumab emtansine in patients with HER2+ metastatic breast cancer ( Dr Javier Cortés - Hospital Universitario Ramón y Cajal, Madrid, Spain )
30 Sep 2021
ESMO 2021: PARPi data and their role in mono/combination therapies
Dr Neal Shore, Prof Fred Saad, Prof Eleni Efstathiou, Prof Andrew Armstrong
ESMO 2021: PARPi data and their role in mono/combination therapies ( Dr Neal Shore, Prof Fred Saad, Prof Eleni Efstathiou, Prof Andrew Armstrong )
29 Sep 2021
Radioembolisation with chemotherapy for colorectal liver metastases
Dr Mary Mulcahy - Northwestern Memorial Hospital, Chicago, USA
Radioembolisation with chemotherapy for colorectal liver metastases ( Dr Mary Mulcahy - Northwestern Memorial Hospital, Chicago, USA )
28 Sep 2021
ESMO 2021: Updates in hormone-sensitive prostate cancer
Prof Eleni Efstathiou, Prof Axel Merseburger, Prof Nicolas Mottet, Dr Elena Cast...
ESMO 2021: Updates in hormone-sensitive prostate cancer ( Prof Eleni Efstathiou, Prof Axel Merseburger, Prof Nicolas Mottet, Dr Elena Castro )
28 Sep 2021
Amivantamab combo with lazertinib favourable in post-osimertinib EGFR-mutant NSC...
Dr Pascale Tomasini and Dr Catherine Shu
Amivantamab combo with lazertinib favourable in post-osimertinib EGFR-mutant NSCLC ( Dr Pascale Tomasini and Dr Catherine Shu )
27 Sep 2021
ESMO 2021: Breast cancer roundup
Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy
ESMO 2021: Breast cancer roundup ( Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy )
27 Sep 2021